Stuka Paul 4
4 · InspireMD, Inc. · Filed May 29, 2026
Research Summary
AI-generated summary of this filing
InspireMD (NSPR) Director Stuka Paul Buys 20,000 Shares
What Happened Stuka Paul, a director of InspireMD, reported an open-market purchase of 20,000 common shares on 2026-05-27. The filing reports a weighted-average price of $0.88 per share and a total reported acquisition value of $17,500. This was a purchase (potentially a positive signal), not a sale or option exercise.
Key Details
- Transaction date: 2026-05-27; filing date: 2026-05-29 (filed within the typical 2-business-day window).
- Price: reported weighted average $0.88; purchases occurred at prices ranging $0.87–$0.88 (per footnote).
- Shares acquired: 20,000; reported total value: $17,500 (as stated in the filing).
- Shares owned after transaction: Not specified in this Form 4.
- Footnotes of note:
- F1: Weighted-average price reflects multiple trades; reporting person can provide breakdown on request.
- F2: Some securities are held by Osiris Investment Partners, L.P.; the reporting person is the managing member of the general partner and disclaims beneficial ownership except for any pecuniary interest.
- Transaction code: P = Purchase (open-market).
Context Director purchases can be of interest to retail investors as one datapoint about insider sentiment, but a single small-dollar purchase ($17.5k) is not definitive. This was a straightforward open-market buy (no option exercise, grant, or gift). Watch for additional filings that might show follow-up activity or clarify post-transaction holdings.
Insider Transaction Report
- Purchase
Common Stock
[F1]2026-05-27$0.88/sh+20,000$17,500→ 667,871 total
- 423,704(indirect: See Footnote)
Common Stock
[F2]
Footnotes (2)
- [F1]The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $0.87 to $0.88. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F2]These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.